Quantbot Technologies’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,396
Closed -$318K 1695
2024
Q1
$318K Sell
2,396
-284
-11% -$37.1K 0.02% 878
2023
Q4
$327K Sell
2,680
-1,170
-30% -$89.5K 0.02% 866
2023
Q3
$293K Buy
+3,850
New +$395K 0.02% 797
2023
Q2
Sell
-875
Closed -$85.9K 1779
2023
Q1
$85.9K Sell
875
-563
-39% -$76.3K 0.01% 1133
2022
Q4
$203K Buy
+1,438
New +$201K 0.01% 893

Other funds holding LABU

Quantbot Technologies's LABU Position: Q2 2024 in Review

Quantbot Technologies sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q2 2024, closing a stake of 2,396 shares — an estimated $318K sold.

Quantbot Technologies first reported a position in LABU in Q4 2022 and held it in 5 quarters. The position peaked at $327K in Q4 2023. 36 funds tracked by Wall St. Rank hold LABU as of Q2 2024.

  • Quantbot Technologies reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q2 2024 after selling out during the quarter.
  • Quantbot Technologies sold 2,396 Direxion Daily S&P Biotech Bull 3X ETF shares in Q2 2024, an estimated $318K.
  • Quantbot Technologies first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q4 2022 and held it in 5 quarters.
  • Quantbot Technologies's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $327K in Q4 2023.
  • 36 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q2 2024.

Based on Quantbot Technologies's 13F filing for Q2 2024, filed 9 Aug 2024.